Unprecedented insights into the inner workings of an early-stage lung tumor: An international research team describes a new method for 3D mapping cellular interactions in the tumor microenvironment.
Leveraging bioink from pancreatic tissue and 3D bioprinting, researchers developed a structure closely mimicking the structure of a pancreas, in which cultured cells can resume insulin production.
Anatomically accurate 3D-printed phantoms for CT imaging and AI training show promise as an alternative to cadavers. The new technology allows for patient-specific phantoms with realistic radiopacity.
Using 3D imaging and deep learning AI, researchers have developed a new way to accurately assess body fat and muscle distribution, which are crucial for understanding health risks.
Patient-specific 3D printed surgical guides could provide a clear visual aid that helps cardiac surgeons locate key treatment areas on the heart, such as the optimal location to build the bypass vein.
Monitoring brainwaves and diagnosing neurological conditions could benefit from a novel 3D printing technology, which applies liquid ink onto a patient’s scalp to measure brain activity.
A newly developed ‘biocooperative’ material based on blood can guide key processes taking place during the natural healing of tissues to create living materials that enhance tissue regeneration.
To take cell therapy in regenerative medicine to a new level, experts consider 3D bioprinting a key technology. However, there are still quality issues that need to be overcome to achieve this.
New insights into metastasis: Scientists created a 3D-printed model to mimic the specific conditions that spur the spread of cancer cells. This could help discover new screening and treatment options.
Researchers have created a mucus-based bioink which can be used for 3D printing lung tissue. This advance could one day help study and treat chronic lung conditions.
A new research project focuses on creating a 3D printed device to grow a human spinal cord organoid for the study of spinal cord injury and subsequent drug testing.
A new 3D graft printing technique offers a potential solution to reduce thrombosis and restrain aneurysmal dilatation post-surgery, with potential for improving cardiovascular disease treatments.
Researchers have developed a cutting-edge method for fabrication of customised pharmaceutical tablets with tailored drug release profiles, ensuring more precise and effective treatment options.
Adding a new dimension to pathology: Researchers explore new, deep learning models that can use 3D pathology datasets to make clinical outcome predictions for curated prostate cancer specimens.
Using 3D bioprinting to accurately replicate the biological environment surrounding gastric cancer cells, researchers predicted a patient’s response to anticancer drugs during the preclinical stage.
Researchers have developed a 3D-bioprinted, miniaturized chip to advance the understanding of cardiovascular disease and aid in the development of new precision treatments.
Material scientists at TU Wien (Vienna) have developed a new approach to producing artificial cartilage tissue: using a 3D printer, cells are grown in microstructures.
A fully digital design-to-manufacturing process developed at Loughborough University has the potential to revolutionise lower limb socket production by allowing printing outside of hospital settings.
A European team of researchers have successfully developed a new, living organ model which could advance rapid testing of new or common drugs to treat diseases of the liver.
